搜索结果

Search Results for " pioglitazone "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T0214	Pioglitazone U 72107,吡格列酮,匹格列酮	Ferroptosis; PPAR	Apoptosis; DNA Damage/DNA Repair; Metabolism
	Pioglitazone (U 72107) 是一种胰岛素增敏剂和噻唑烷二酮，适用于治疗 2 型糖尿病。它是一种选择性PPARγ激动剂，高亲和力结合到 PPARγ 配体结合域，作用于人和鼠 PPARγ的EC50分别为 0.93 和 0.99 μM。
T0214L	Pioglitazone hydrochloride U-72107E,AD 4833,U 72107A,Pioglitazone HCl,匹格列酮盐酸盐	Ferroptosis; PPAR	Apoptosis; DNA Damage/DNA Repair; Metabolism
	Pioglitazone hydrochloride (AD 4833) 是一种选择性PPARγ激动剂，高亲和力结合到 PPARγ 配体结合域。作用于人和鼠 PPARγ，EC50分别为 0.93 和 0.99 μM。它是一种口服活性噻唑烷二酮的盐酸盐，具有抗糖尿病特性和潜在的抗肿瘤活性。
T12479	Pioglitazone-d4 U 72107 D4	Others	Others
	Pioglitazone D4 is a deuterium labeled Pioglitazone. Pioglitazone is a agonist of PPARγ .
T20465	Ketopioglitazone Keto pioglitazone,Pioglitazone metabolite M3
	Ketopioglitazone is an active metabolite of pioglitazone.
T61836	Pioglitazone potassium
	Pioglitazone potassium (U 72107) is an orally active and selective agonist of peroxisome proliferator-activated receptor gamma (PPARγ). It demonstrates high affinity binding to the ligand-binding domain of PPARγ, with an EC50 of 0.93 μM and 0.99 μM for human and mouse PPARγ, respectively. Pioglitazone potassium has applications in diabetes research [2] [3] [4].
T27210	DRX-065 DRX 065,DRX065,deuterated R-enantiomer of pioglitazone
	DRX-065 is a stabilized and deuterated R-enantiomer of pioglitazone. DRX-065 has pharmacological properties desirable for the treatment of NASH (mitochondrial function modulation, non-steroidal anti-inflammatory effects, and glucose lowering effects) with
T15736	Leriglitazone Hydroxypioglitazone	Others	Others
	Leriglitazone, a metabolite of pioglitazone, binds to the PPARγ C-terminal ligand-binding domain (Ki: 1.2 μM) and induces transcriptional efficacy of the PPARγ (EC50: 680 nM). Leriglitazone PioOH is a PPARγ agonist, stabilizes the PPARγ activation functio
T73842	Leriglitazone hydrochloride
	Leriglitazone (Hydroxypioglitazone) hydrochloride，吡格列酮的代谢产物。Leriglitazone (Hydroxypioglitazone) hydrochloride 是PPARγ激动剂，通过稳定PPARγ(AF-2) 共激活剂结合表面和增强共激活剂结合能力，提供高转录效力。 Leriglitazone (Hydroxypioglitazone) hydrochloride 与 PPARγC (LBD) 结合，其Ki 值为 1.2 μM，诱导PPARγ(LBD) 转录效率，EC50为 680 nM。
T28542	Rivoglitazone HCl CI-1037,CI1037,CS011,CS-011,CI 1037
	Rivoglitazone, also known as CI-1037; CS-011; DE-101; R-119702; Rivo, is a peroxisome proliferator-activated receptor γ agonist (PARPγ agonist) potentially for the treatment of type 2 diabetes. Rivoglitazone has been shown, through small clinical studies,